Bayer AG and Perfuse Therapeutics Inc. have announced an agreement under which Bayer will fully acquire Perfuse Therapeutics, ...

R. Jude Samulski, Ph.D., was honored by the American Society of Gene + Cell Therapy (ASGCT) with its Founders Award at the ...

North Carolina Agricultural and Technical State University will collaborate with another historically Black college and ...

Durham-based BioCryst Pharmaceuticals, a global biotechnology company focused on developing and commercializing medicines for rare diseases, has signed a European licensing agreement for one of its ...

The Alexandria Center for Life Science - Durham North Campus (ACLS-D), at 42 Moore Drive, won the distinction. It’s located ...

To celebrate 30 years of manufacturing investment, innovation, workforce development and community partnership in North Carolina’s Research Triangle Park (RTP), Biogen leaders and employees hosted a ...

The Innovation Impact Grant (IIG) program supports the purchase of shared-use research equipment for core facilities at academic or nonprofit institutions that foster innovation within North ...

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

Biotechnology pioneer Genentech broke ground Monday on a $700 million manufacturing facility in Holly Springs, marking the company's first production site on the East Coast and a significant expansion ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and Drug Administration for its first product – a groundbreaking bioengineered ...

Long-time Triangle ag-biotech executive Toni Bucci, Ph.D., has a clear vision for her new company, Sable Fermentation Inc.: Enable manufacturing and commercialization of agricultural and other ...